Verve Therapeutics, Inc.: SCHEDULE 13G filed Aug 14, 2025

Form type

SCHEDULE 13G

Filing date

Aug 14, 2025

Accession number

0000902664-25-003639

Filer

Verve Therapeutics, Inc. (CIK 1840574)